Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Curcumin vs Corticosteroid in Oral Lichen Planus
NCT03877679Phase 1Unknown
- Sponsor
- Cairo University
- Start
- May 2019
- Primary completion
- May 2020
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
Phase 1, randomised, open-label trial of curcumin in oral lichen planus (OLP) (2 arms), sponsored by Cairo University. Primary endpoint: Pain intensity at 4 weeks. Status: unknown.
02
Drugs
curcumin
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on NCT03877679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03877679.